Annual Debt To Equity
-2.83
-32.94-109.40%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual debt to equity ratio is -2.83, with the most recent change of -32.94 (-109.40%) on December 31, 2023.
- During the last 3 years, RVNC annual debt to equity has fallen by -3.31 (-689.58%).
- RVNC annual debt to equity is now -109.40% below its all-time high of 30.11, reached on December 31, 2022.
Performance
RVNC Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-2.64
+0.68+20.48%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly debt to equity ratio is -2.64, with the most recent change of +0.68 (+20.48%) on September 30, 2024.
- Over the past year, RVNC quarterly debt to equity has increased by +1.39 (+34.49%).
- RVNC quarterly debt to equity is now -108.77% below its all-time high of 30.11, reached on December 31, 2022.
Performance
RVNC Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RVNC Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -109.4% | +34.5% |
| 3 y3 years | -689.6% | -213.3% |
| 5 y5 years | -100.0% | -100.0% |
RVNC Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -109.4% | at low | -108.8% | +98.2% |
| 5 y | 5-year | -109.4% | at low | -108.8% | +98.2% |
| alltime | all time | -109.4% | at low | -108.8% | +98.2% |
Revance Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -2.64(-20.5%) |
| Jun 2024 | - | -3.32(-23.9%) |
| Mar 2024 | - | -4.36(+54.1%) |
| Dec 2023 | -2.83(-109.4%) | -2.83(-29.8%) |
| Sep 2023 | - | -4.03(-128.4%) |
| Jun 2023 | - | 14.20(-199.7%) |
| Mar 2023 | - | -14.24(-147.3%) |
| Dec 2022 | 30.11(+634.4%) | 30.11(+1058.1%) |
| Sep 2022 | - | 2.60(-101.8%) |
| Jun 2022 | - | -143.82(-1071.8%) |
| Mar 2022 | - | 14.80(+261.0%) |
| Dec 2021 | 4.10(+754.2%) | 4.10(+76.0%) |
| Sep 2021 | - | 2.33(+55.3%) |
| Jun 2021 | - | 1.50(+30.4%) |
| Mar 2021 | - | 1.15(+139.6%) |
| Dec 2020 | 0.48(>+9900.0%) | 0.48(0.0%) |
| Sep 2020 | - | 0.48(-29.4%) |
| Jun 2020 | - | 0.68(+21.4%) |
| Mar 2020 | - | 0.56(>+9900.0%) |
| Dec 2019 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2019 | - | 0.00(0.0%) |
| Jun 2019 | - | 0.00(0.0%) |
| Mar 2019 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2018 | - | 0.00(0.0%) |
| Jun 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2017 | - | 0.00(0.0%) |
| Jun 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(0.0%) |
| Jun 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(-100.0%) |
| Dec 2014 | 0.01(-106.3%) | 0.01(-80.0%) |
| Sep 2014 | - | 0.05(0.0%) |
| Jun 2014 | - | 0.05(-72.2%) |
| Mar 2014 | - | 0.18(-212.5%) |
| Dec 2013 | -0.16(-67.3%) | -0.16(-72.4%) |
| Sep 2013 | - | -0.58(+18.4%) |
| Dec 2012 | -0.49(+14.0%) | -0.49 |
| Dec 2011 | -0.43 | - |
FAQ
- What is Revance Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Revance Therapeutics?
- What is Revance Therapeutics annual debt to equity year-on-year change?
- What is Revance Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Revance Therapeutics?
- What is Revance Therapeutics quarterly debt to equity year-on-year change?
What is Revance Therapeutics annual debt to equity ratio?
The current annual debt to equity of RVNC is -2.83
What is the all time high annual debt to equity for Revance Therapeutics?
Revance Therapeutics all-time high annual debt to equity ratio is 30.11
What is Revance Therapeutics annual debt to equity year-on-year change?
Over the past year, RVNC annual debt to equity ratio has changed by -32.94 (-109.40%)
What is Revance Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of RVNC is -2.64
What is the all time high quarterly debt to equity for Revance Therapeutics?
Revance Therapeutics all-time high quarterly debt to equity ratio is 30.11
What is Revance Therapeutics quarterly debt to equity year-on-year change?
Over the past year, RVNC quarterly debt to equity ratio has changed by +1.39 (+34.49%)